PHREESIA ($PHR) posted quarterly earnings results for Q3 2026 on Monday, December 8th. The company reported earnings of $0.10 per share, beating estimates of $0.00 by $0.10. The company also reported revenue of $120,330,000, missing estimates of $121,252,580 by $-922,580.
You can see Quiver Quantitative's $PHR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PHREESIA Insider Trading Activity
PHREESIA insiders have traded $PHR stock on the open market 47 times in the past 6 months. Of those trades, 0 have been purchases and 47 have been sales.
Here’s a breakdown of recent trading of $PHR stock by insiders over the last 6 months:
- CHAIM INDIG (Chief Executive Officer) has made 0 purchases and 5 sales selling 112,655 shares for an estimated $3,508,238.
- EVAN ROBERTS (President, Provider Solutions) has made 0 purchases and 5 sales selling 56,088 shares for an estimated $1,736,630.
- DAVID LINETSKY (President, Network Solutions) has made 0 purchases and 11 sales selling 48,805 shares for an estimated $1,379,073.
- AMY BETH VANDUYN (SVP, Human Resources) has made 0 purchases and 4 sales selling 21,614 shares for an estimated $636,577.
- MICHAEL WEINTRAUB has made 0 purchases and 3 sales selling 20,000 shares for an estimated $576,011.
- BALAJI GANDHI (Chief Financial Officer) has made 0 purchases and 4 sales selling 15,537 shares for an estimated $428,559.
- MARK DOUGLAS SMITH sold 7,000 shares for an estimated $203,000
- ALLISON C HOFFMAN (General Counsel & Secretary) has made 0 purchases and 4 sales selling 7,678 shares for an estimated $182,559.
- YVONNE HUI (Principal Accounting Officer) has made 0 purchases and 8 sales selling 4,215 shares for an estimated $110,283.
- LISA EGBUONU-DAVIS has made 0 purchases and 2 sales selling 3,267 shares for an estimated $90,383.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PHREESIA Hedge Fund Activity
We have seen 132 institutional investors add shares of PHREESIA stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BROWN ADVISORY INC removed 1,659,152 shares (-66.8%) from their portfolio in Q3 2025, for an estimated $39,023,255
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,209,449 shares (+58.3%) to their portfolio in Q3 2025, for an estimated $28,446,240
- FMR LLC removed 976,190 shares (-19.9%) from their portfolio in Q3 2025, for an estimated $22,959,988
- MILLENNIUM MANAGEMENT LLC added 936,033 shares (+730.7%) to their portfolio in Q3 2025, for an estimated $22,015,496
- MACQUARIE GROUP LTD added 690,684 shares (+755.7%) to their portfolio in Q3 2025, for an estimated $16,244,887
- GREENHOUSE FUNDS LLLP added 557,265 shares (+16.8%) to their portfolio in Q3 2025, for an estimated $13,106,872
- CITADEL ADVISORS LLC removed 528,603 shares (-93.2%) from their portfolio in Q3 2025, for an estimated $12,432,742
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PHREESIA Congressional Stock Trading
Members of Congress have traded $PHR stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $PHR stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 10/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PHREESIA Analyst Ratings
Wall Street analysts have issued reports on $PHR in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 12/08/2025
- DA Davidson issued a "Buy" rating on 12/02/2025
- BMO Capital issued a "Outperform" rating on 11/13/2025
- Keybanc issued a "Overweight" rating on 10/08/2025
- Truist Securities issued a "Buy" rating on 09/08/2025
- JMP Securities issued a "Market Outperform" rating on 09/08/2025
To track analyst ratings and price targets for PHREESIA, check out Quiver Quantitative's $PHR forecast page.
PHREESIA Price Targets
Multiple analysts have issued price targets for $PHR recently. We have seen 12 analysts offer price targets for $PHR in the last 6 months, with a median target of $34.5.
Here are some recent targets:
- Ryan MacDonald from Needham set a target price of $35.0 on 12/08/2025
- Clark Wright from DA Davidson set a target price of $35.0 on 12/02/2025
- Sean Dodge from BMO Capital set a target price of $32.0 on 11/13/2025
- Scott Schoenhaus from Keybanc set a target price of $32.0 on 10/08/2025
- Jailendra Singh from Truist Securities set a target price of $36.0 on 09/08/2025
- Silvan Tuerkcan from JMP Securities set a target price of $34.0 on 09/08/2025
- Jessica Tassan from Piper Sandler set a target price of $34.0 on 09/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
